AMBER WOOD: Open Payments
NPI 1750878039 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,474 in 76 payments from 14 companies in 2025. Trend: 2023 $340 · 2024 $1,592 · 2025 $1,474
Food & beverage: $1,362Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $335 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $223 |
| Teva Pharmaceuticals USA, Inc. | 6 | $195 |
| Alkermes, Inc. | 6 | $143 |
| Vanda Pharmaceuticals Inc. | 4 | $126 |
| Otsuka America Pharmaceutical, Inc. | 5 | $104 |
| Collegium Pharmaceutical, Inc. | 4 | $79 |
| Supernus Pharmaceuticals, Inc. | 4 | $63 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
| Axsome Therapeutics, Inc. | 2 | $49 |
Products named: VRAYLAR, CAPLYTA, ARISTADA, Jornay PM, HETLIOZ, Qelbree, ABILIFY MAINTENA, FANAPT.
Industry payments across KY — which companies pay providers there.
